ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,891, issued on May 19, was assigned to Gen-Probe Inc. (San Diego).

"Compositions and methods for detecting or quantifying hepatitis B virus" was invented by Kui Gao (San Diego) and Jeffrey M. Linnen (Poway, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis B virus (HBV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the P and/or S open reading frames of HBV and are configured to provide substantially equivalent quantification of different genotypes and variants of HBV."

The p...